Answers are grounded in this paper and cite their sources.
This multicenter study validated single-center evidence that patients who received kidney transplants from HLA-incompatible live donors had a substantial survival benefit as compared with patients who did not undergo transplantation and those who waited for transplants from deceased donors. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases.).
No takes yet. Share an insight, caveat, or question.
Orandi et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: